Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's disease.

Neurobiol Aging · 2021 · PMC7762821 · PMID 32873436

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

Analysis of carriers of a common LRRK2 risk single nucleotide polymorphism provided nominally significant support for a potential interaction between VAMP4 and LRRK2 , which requires replication in larger sample sizes.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.